Showing results (331-340 of 384) with videos related to

Sort By:
Pageof 39
International Journal of Clinical Practice|October 9, 2021
Is there a role for natural desiccated thyroid in the treatment of levothyroxine unresponsive hypothyroidism? Results from a consecutive case seriesAdrian H Heald, Lakdasa Premawardhana, Peter Taylor, et al.
European Thyroid Journal|March 29, 2021
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus DocumentJacqueline Jonklaas, Antonio C Bianco, Anne R Cappola, et al.
Molecular and Cellular Endocrinology|March 28, 2006
Characteristics of the Danish families with multiple endocrine neoplasia type 1Anne Charlotte Jäger, Lennart Friis-Hansen, Thomas V O Hansen, et al.
Endocrine Connections|December 15, 2018
Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide studyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Thyroid : Official Journal of the American Thyroid Association|December 5, 2020
Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus DocumentJacqueline Jonklaas, Antonio C Bianco, Anne R Cappola, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2023
Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug TherapyAnn-Elin Meling Stokland, Marie Austdal, Bjørn Gunnar Nedrebø, et al.
Thyroid Research|April 11, 2023
Hyperthyroidism in pregnancy: design and methodology of a Danish multicenter studyNanna Maria Uldall Torp, Inge Bülow Pedersen, Allan Carlé, et al.
Clinical Epidemiology|October 24, 2018
Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901-2014: a nationwide studyJes Sloth Mathiesen, Jens Peter Kroustrup, Peter Vestergaard, et al.
Cancers|April 13, 2023
Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective StudyMagnus Holm, Peter Vestergaard, Morten Møller Poulsen, et al.
Molecular Genetics and Metabolism|January 29, 2023
Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry RegistryRobert J Hopkin, Gustavo H Cabrera, John L Jefferies, et al.
Pageof 39